221 related articles for article (PubMed ID: 20720484)
1. Use of heptaminol hydrochloride for catecholamine weaning in septic shock.
Bahloul M; Chaari A; Ben Mbarek MN; Kallel H; Bouaziz M
Am J Ther; 2012 Jan; 19(1):e8-17. PubMed ID: 20720484
[TBL] [Abstract][Full Text] [Related]
2. Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study).
Póvoa PR; Carneiro AH; Ribeiro OS; Pereira AC;
Crit Care Med; 2009 Feb; 37(2):410-6. PubMed ID: 19114885
[TBL] [Abstract][Full Text] [Related]
3. Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study.
Sakr Y; Reinhart K; Vincent JL; Sprung CL; Moreno R; Ranieri VM; De Backer D; Payen D
Crit Care Med; 2006 Mar; 34(3):589-97. PubMed ID: 16505643
[TBL] [Abstract][Full Text] [Related]
4. Comparison of systemic and renal effects of dopexamine and dopamine in norepinephrine-treated septic shock.
Schmoelz M; Schelling G; Dunker M; Irlbeck M
J Cardiothorac Vasc Anesth; 2006 Apr; 20(2):173-8. PubMed ID: 16616656
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
Watson D; Grover R; Anzueto A; Lorente J; Smithies M; Bellomo R; Guntupalli K; Grossman S; Donaldson J; Le Gall JR;
Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of dopamine versus norepinephrine in the management of septic shock.
Patel GP; Grahe JS; Sperry M; Singla S; Elpern E; Lateef O; Balk RA
Shock; 2010 Apr; 33(4):375-80. PubMed ID: 19851126
[TBL] [Abstract][Full Text] [Related]
7. Terlipressin in the treatment of late phase catecholamine-resistant septic shock.
Svoboda P; Scheer P; Kantorová I; Doubek J; Dudra J; Radvan M; Radvanova J
Hepatogastroenterology; 2012 Jun; 59(116):1043-7. PubMed ID: 22580654
[TBL] [Abstract][Full Text] [Related]
8. Dopamine therapy in septic shock: detrimental effect on survival?
Boulain T; Runge I; Bercault N; Benzekri-Lefevre D; Wolf M; Fleury C
J Crit Care; 2009 Dec; 24(4):575-82. PubMed ID: 19327324
[TBL] [Abstract][Full Text] [Related]
9. [A clinical study of pituitrin versus norepinephrine in the treatment of patients with septic shock].
Han XD; Sun H; Huang XY; Zhang SY; Wang YD; Ren K; Li F
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Jan; 24(1):33-7. PubMed ID: 22248749
[TBL] [Abstract][Full Text] [Related]
10. Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best?
De Backer D; Creteur J; Silva E; Vincent JL
Crit Care Med; 2003 Jun; 31(6):1659-67. PubMed ID: 12794401
[TBL] [Abstract][Full Text] [Related]
11. [The effect of low-dose hydrocortisone on requirement of norepinephrine and lactate clearance in patients with refractory septic shock].
Hu B; Li JG; Liang H; Zhou Q; Yu Z; Li L; Luo Y; Liu C; Gan Q
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Sep; 21(9):529-31. PubMed ID: 19751560
[TBL] [Abstract][Full Text] [Related]
12. Refractory septic shock: efficacy and safety of very high doses of norepinephrine.
Katsaragakis S; Kapralou A; Theodorou D; Markogiannakis H; Larentzakis A; Stamou KM; Drimousis P; Bramis I
Methods Find Exp Clin Pharmacol; 2006 Jun; 28(5):307-13. PubMed ID: 16845448
[TBL] [Abstract][Full Text] [Related]
13. Impact of a recent chemotherapy on the duration and intensity of the norepinephrine support during septic shock.
Schnell D; Besset S; Lengliné E; Maziers N; Zafrani L; Reuter D; Moreau AS; Canet E; Lemiale V; Azoulay E
Shock; 2013 Feb; 39(2):138-43. PubMed ID: 23324882
[TBL] [Abstract][Full Text] [Related]
14. Vasopressor use in septic shock: an update.
Leone M; Martin C
Curr Opin Anaesthesiol; 2008 Apr; 21(2):141-7. PubMed ID: 18443479
[TBL] [Abstract][Full Text] [Related]
15. Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock.
Hall LG; Oyen LJ; Taner CB; Cullinane DC; Baird TK; Cha SS; Sawyer MD
Pharmacotherapy; 2004 Aug; 24(8):1002-12. PubMed ID: 15338849
[TBL] [Abstract][Full Text] [Related]
16. Diastolic arterial blood pressure: a reliable early predictor of survival in human septic shock.
Benchekroune S; Karpati PC; Berton C; Nathan C; Mateo J; Chaara M; Riché F; Laisné MJ; Payen D; Mebazaa A
J Trauma; 2008 May; 64(5):1188-95. PubMed ID: 18469640
[TBL] [Abstract][Full Text] [Related]
17. Changes in vasopressin use and outcomes in surgical intensive care unit patients with septic shock.
Lupei MI; Beilman GJ; Chipman JG; Mann HJ
Chirurgia (Bucur); 2009; 104(5):575-81. PubMed ID: 19943557
[TBL] [Abstract][Full Text] [Related]
18. High-dose vasopressin is not superior to norepinephrine in septic shock.
Klinzing S; Simon M; Reinhart K; Bredle DL; Meier-Hellmann A
Crit Care Med; 2003 Nov; 31(11):2646-50. PubMed ID: 14605537
[TBL] [Abstract][Full Text] [Related]
19. Effects of continuous vasopressin infusion in patients with septic shock.
Obritsch MD; Jung R; Fish DN; MacLaren R
Ann Pharmacother; 2004; 38(7-8):1117-22. PubMed ID: 15178740
[TBL] [Abstract][Full Text] [Related]
20. Early prediction of norepinephrine dependency and refractory septic shock with a multimodal approach of vascular failure.
Conrad M; Perez P; Thivilier C; Levy B
J Crit Care; 2015 Aug; 30(4):739-43. PubMed ID: 25900257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
